The impact of osteoporosis on spinal biomechanical stability in adolescent idiopathic scoliosis: a narrative review of finite element analysis and bone mineral density assessment.
IF 5.8 3区 工程技术Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Zhaomeng Hou, Jiaojiao Wu, Hua Lu, Chaoqun Chen, Tingliang Han
{"title":"The impact of osteoporosis on spinal biomechanical stability in adolescent idiopathic scoliosis: a narrative review of finite element analysis and bone mineral density assessment.","authors":"Zhaomeng Hou, Jiaojiao Wu, Hua Lu, Chaoqun Chen, Tingliang Han","doi":"10.3389/fbioe.2026.1908609","DOIUrl":null,"url":null,"abstract":"<p><p>Adolescent Idiopathic Scoliosis (AIS) is a complex three-dimensional spinal deformity whose precise etiology and pathological mechanisms remain incompletely understood. In recent years, increasing attention has focused on the association between the prevalent phenomenon of reduced bone mineral density (BMD) and osteoporosis in AIS patients and spinal biomechanical stability. This review aims to summarize the epidemiological characteristics and assessment methods of osteoporosis in AIS, with a primary focus on elucidating how it contributes to curve progression by influencing the spine's mechanical properties. By integrating clinical BMD assessment data with analyses from patient-specific, image-based finite element models of the spine, this article systematically elaborates on the specific mechanisms by which osteoporosis affects the biomechanical stability of the AIS spine. These mechanisms encompass vertebral body strength, spinal flexibility, the risk of curve progression, and the outcomes of internal fixation surgery. This review provides novel perspectives and a theoretical foundation for a deeper understanding of AIS pathophysiology and for optimizing clinical assessment and developing individualized prevention and treatment strategies.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"14 ","pages":"1908609"},"PeriodicalIF":5.8000,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13680873/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2026.1908609","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Adolescent Idiopathic Scoliosis (AIS) is a complex three-dimensional spinal deformity whose precise etiology and pathological mechanisms remain incompletely understood. In recent years, increasing attention has focused on the association between the prevalent phenomenon of reduced bone mineral density (BMD) and osteoporosis in AIS patients and spinal biomechanical stability. This review aims to summarize the epidemiological characteristics and assessment methods of osteoporosis in AIS, with a primary focus on elucidating how it contributes to curve progression by influencing the spine's mechanical properties. By integrating clinical BMD assessment data with analyses from patient-specific, image-based finite element models of the spine, this article systematically elaborates on the specific mechanisms by which osteoporosis affects the biomechanical stability of the AIS spine. These mechanisms encompass vertebral body strength, spinal flexibility, the risk of curve progression, and the outcomes of internal fixation surgery. This review provides novel perspectives and a theoretical foundation for a deeper understanding of AIS pathophysiology and for optimizing clinical assessment and developing individualized prevention and treatment strategies.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.